Medivir to present at the Redeye Fight Cancer Event

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Event, today January 22, 2025.

CEO Jens Lindberg will present the company and data from the recently finalized phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) at 14.38 CET.

The presentation is live broadcasted and can be followed at the event page;
https://www.redeye.se/events/1052608/redeye-theme-fight-cancer-3
The presentation will be available after the meeting on Medivirs website; www.medivir.com

Datum 2025-01-22, kl 12:00
Källa MFN
Bifogade filer
Ungdomsdeal - 200 kr ! Just nu får alla nya kunder mellan 18 och 25 år 200 kr gratis när man skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra läge att testa Nordnet!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet